Serum DLL-1 levels are significantly higher in patients with chronic heart failure than in healthy individuals, and DLL-1 levels have been significantly associated with diastolic dysfunction, decreased exercise capacity, increased levels of C-reactive protein (CRP), and adverse (Norum et al., 2016). Here, CRP is linked to congestive heart failure.